ACWRF yields 153846.15% · JNJ yields 2.13%● Live data
📍 ACWRF pulled ahead of the other in Year 1
Combined, ACWRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACWRF + JNJ for your $10,000?
Acceleware Ltd. operates as an oil and gas technology company in Canada and the United States. The company operates through two segments, RF Heating and High-Performance Computing. It develops an enhanced heavy oil and oil sands production technology based on radio frequency (RF) heating; and develops and markets computational software products for the oil and gas, and other markets. The company's solutions include AxFDTD, an electromagnetic modeling software to measure RF energy absorption; AxHeat RF heating simulation software; AxRTM, a graphics processing unit accelerated Kirchhoff time migration solution; AxWAVE, a solution that allows customers to model seismic acquisition and perform data characterization; AxFWI, a revolutionary modular full waveform inversion application for providing subsurface velocity models. It also sells computing software and related consulting services, and training programs primarily to the oil and gas industry. The company was founded in 2004 and is headquartered in Calgary, Canada.
Full ACWRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.